Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbons

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|February 28, 2012
Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)Chandrakala Pidathala, Richard Amewu, Bénédicte Pacorel, et al.
Journal of Medicinal Chemistry|February 28, 2012
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)Suet C Leung, Peter Gibbons, Richard Amewu, et al.
Journal of Medicinal Chemistry|March 3, 2012
Identification of novel antimalarial chemotypes via chemoinformatic compound selection methods for a high-throughput screening program against the novel malarial target, PfNDH2: increasing hit rate via virtual screening methodsRaman Sharma, Alexandre S Lawrenson, Nicholas E Fisher, et al.
Journal of Medicinal Chemistry|February 19, 2009
Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st centuryPaul M O'Neill, B Kevin Park, Alison E Shone, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2012
Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malariaGiancarlo A Biagini, Nicholas Fisher, Alison E Shone, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|February 28, 2012
Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)Chandrakala Pidathala, Richard Amewu, Bénédicte Pacorel, et al.
Journal of Medicinal Chemistry|February 28, 2012
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)Suet C Leung, Peter Gibbons, Richard Amewu, et al.
Journal of Medicinal Chemistry|March 3, 2012
Identification of novel antimalarial chemotypes via chemoinformatic compound selection methods for a high-throughput screening program against the novel malarial target, PfNDH2: increasing hit rate via virtual screening methodsRaman Sharma, Alexandre S Lawrenson, Nicholas E Fisher, et al.
Journal of Medicinal Chemistry|February 19, 2009
Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st centuryPaul M O'Neill, B Kevin Park, Alison E Shone, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2012
Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malariaGiancarlo A Biagini, Nicholas Fisher, Alison E Shone, et al.
Pageof 2